Skip to main content

Table 2 Transplant surgery and years since transplant in the study (n = 93) and lung transplant recipients with/without PRA (n = 23 vs 70, respectively)

From: The fraction of sensitization among lung transplant recipients in a transplant center in Japan

  Total (n = 93) PRA+ (n = 23) PRA- (n = 70) p-value
CMV mismatch (D+/R-)a 16 (17.2%) 1 (4.3%) 15 (21.4%) 0.058
Donor age$     0.110
  ≤ 19 9 (9.7%) 0 (0%) 9 (12.9%)  
20–59 79 (84.9%) 20 (87.0%) 59 (84.3%)  
  ≥ 60 4 (4.3%) 2 (8.7%) 2 (2.9%)  
Operative time (min)     0.868
  ≤ 419 24 (25.8%) 5 (21.7%) 19 (27.1%)  
420–839 47 (50.5%) 12 (52.2%) 35 (50.0%)  
  ≥ 840 22 (23.7%) 6 (26.1%) 16 (22.9%)  
Ischemic time (min)b     0.861
  ≤ 419 21 (22.6%) 5 (21.7%) 16 (22.9%)  
420–599 42 (45.2%) 9 (39.1%) 33 (47.1%)  
  ≥ 600 29 (31.2%) 8 (34.8%) 21 (30.0%)  
Yeas since transplant     0.048
  ≤ 5 years 40 (43.0%) 14 (60.9%) 26 (37.1%)  
5–10 years 36 (38.7%) 4 (17.4%) 32 (45.7%)  
  ≥ 10 years 17 (18.3%) 5 (21.7%) 12 (17.1%)  
  1. Abbreviation: PRA panel-reactive assay, CMV cytomegalovirus, D donor, R recipient
  2. amissing the CMV serology in 17 recipients (n = 76), $missing the age in one donor (n = 92) and bmissing the ischemic time in one recipient (n = 92)